The ASRS-5, explained

Short answer

The ASRS-5, also called the ASRS DSM-5, is a self-report questionnaire for adults that Lenard Adler and Ronald Kessler updated to DSM-5 criteria. It has its own six-question screener, a symptom checklist and proprietary scoring. It is a separate instrument from the ASRS v1.1 screener on this site, and NYU licenses it separately.

Start the free screener

Two adult self-report scales carry nearly the same name, and both trace back to the same two researchers. That makes them easy to mix up. The ASRS v1.1 Screener, the one you can take free on ADHDFalcon, was built on the older DSM-IV criteria. The ASRS-5 is a later instrument written for the DSM-5.

Full name
Adult ADHD Self-Report Scale for DSM-5 (ASRS DSM-5, often shortened to ASRS-5)
Developers
Lenard Adler, MD (NYU) and Ronald C. Kessler, PhD (Harvard)
Licensor
NYU Langone Health, Technology Opportunities & Ventures
Format
Self-report questionnaire for adults 18+
Parts
A six-question screener and a symptom checklist with proprietary scoring rules

Why a DSM-5 version was needed

The way the screener was built is also different. Instead of choosing questions with the older statistical method, the team used a machine-learning approach designed to produce short scales with whole-number weights. In plain terms, some answers count for more than others when the screener is scored.

Who can use it, and on what terms

That last point matters. If a clinic wants to use the ASRS-5 with patients, the licensing questions go to NYU, not to a website. We do not offer the ASRS-5 on ADHDFalcon, and we do not reproduce its questions or scoring anywhere.

How it differs from the screener on this site

ASRS v1.1 Screener and ASRS-5 side by side
ASRS v1.1 Screener (offered here)ASRS-5
Criteria it was written forDSM-IVDSM-5
Length of the screenerSix questionsSix questions
How the screener is scoredCount answers that fall in shaded boxesWeighted scoring rules set by the developers
License shown by NYUFree for clinical and non-clinical use, with attribution, electronic versions allowedResearch and academic license listed

Neither version is a diagnosis, and this page does not rank them. They answer slightly different design goals. We offer v1.1 because its license allows a free electronic version for the public, with attribution.

What the ASRS-5 does not do

If you want to try a screener today

The free screener here is the official six-question ASRS v1.1, © New York University and the President and Fellows of Harvard College. It asks about the past six months and gives the official outcome at no cost. If a clinician later uses the ASRS-5 or another scale with you, your v1.1 result is still useful background to bring along. Write down the date you took it and any examples that came to mind while answering, since those details often matter more in an appointment than the outcome itself.

The 6-question Adult Self-Report Scale-Version1.1 (ASRS-V1.1) Screener is a subset of the 18-question Adult ADHD Self-Report Scale-Version1.1 (Adult ASRSV1.1) Symptom Checklist.

© New York University and the President and Fellows of Harvard College.

Frequently asked questions

Are the ASRS-5 and the ASRS v1.1 one instrument?

No. Both come from Lenard Adler and Ronald Kessler, but the ASRS-5 was written for DSM-5 criteria, uses its own weighted scoring and is licensed separately by NYU. The ASRS v1.1 Screener on this site was built on DSM-IV criteria.

Can I take the ASRS-5 on ADHDFalcon?

No. We offer only the six-question ASRS v1.1 Screener, whose license permits a free electronic version. NYU lists the ASRS-5 under a research and academic license, and we do not reproduce its questions.

Does a positive result on either screener mean ADHD?

No. A screener suggests whether a full evaluation may be worthwhile. Only a qualified clinician can make a diagnosis, using an interview, history and other information.

Sources

Source check: 2026-10-28. No medical review has occurred.

Published 2026-10-28. Factual source check: ADHDFalcon editorial team, factual source check, 2026-10-28. No medical review has occurred.